ALLERGIC ASTHMA

This study tests a new drug called FB825 in 100 adults with moderate-to-severe allergic asthma. The goal is to see if it can reduce asthma attacks and improve breathing compared to a placebo. Participants will receive either the drug or a placebo and be monitored for 24 weeks.

This study follows 225 adults with chronic spontaneous urticaria (hives) or allergic asthma whose disease is well-controlled on a standard biologic drug. Their doctor has decided to switch them to a biosimilar called Omlyclo®. The main goal is to see if they stay stable for 12 mo…

This study looks at whether a simple skin test can help doctors choose the right medicine for children with allergic asthma. About 300 African American and Caucasian children ages 6-17 with uncontrolled asthma will receive either an antihistamine or a placebo. The goal is to see …

This study is testing an investigational injection called LP-003 for adults with moderate to severe allergic asthma that isn't fully controlled with standard inhalers. The goal is to see if the injection can reduce the number of asthma flare-ups, improve breathing, and enhance qu…

This study tests a new way to treat cat allergies by injecting a small amount of cat allergen directly into a lymph node in the groin. The goal is to see if this approach is safe and well-tolerated in 36 adults with cat allergy and asthma. Researchers will monitor allergic reacti…

This study is for adults with hay fever living in South-Eastern Australia. Researchers want to find out who is most at risk for thunderstorm asthma, a dangerous condition that can occur during spring pollen season. Participants will be tested for grass pollen allergy, do simple b…